Healthtech Software M&A Deals (2026) (page 3)
Announced acquisitions of healthtech software and technology-enabled health companies, tracked from public sources with a source link on every row. The ProCloser ledger is tech-only, so this page covers healthtech software and technology companies, not healthcare services providers or medical practices. Part of the ProCloser Tech & SaaS M&A Deal Index.
ProCloser tracks 142 Healthtech deals in its Tech M&A Deal Index, 13 announced in the last 30 days, covering Jan 7, 2026 to Nov 17, 2026.
The largest disclosed Healthtech deal is Qualtrics's acquisition of Press Ganey Forsta for $6.75 billion (Press release).
21 of 142 deals disclosed a value; the others are listed as undisclosed.
The most active acquirers in this cut are Banyan Software (2), Thoma Bravo (2) and Veeva Systems (2).
Private equity buyers account for 19% of Healthtech deals; 16% were cross-border.
16 of 142 deals (11%) name an advisor in the public source; the other 126 are listed with no advisor rather than guessed.
Last updated Nov 18, 2026.
About this page
This page collects announced acquisitions of healthtech software and technology-enabled health companies. It currently lists 142 deals announced between Jan 7, 2026 and Nov 17, 2026, with 13 added in the last 30 days. The largest disclosed transaction is Qualtrics's purchase of Press Ganey Forsta for $6.75 billion. 21 of the 142 deals carry a disclosed value; the remaining 121 were announced without terms and are shown as undisclosed rather than estimated. Across the cut, strategic buyers led with 86 deals and 23 deals crossed a border. Repeat acquirers include Banyan Software (2), Thoma Bravo (2) and Veeva Systems (2) and advisors credited in public sources include Bailey & Company (2), TripleTree (2) and Houlihan Lokey (2). Use the filters to narrow by buyer type, size or geography, or download the CSV and JSON for your own analysis. Every row links to the public source it was taken from.
Deals this month: Nov 2026
11 deals were announced in Nov 2026 so far, 2 with a disclosed value and 0 naming an advisor in the source.
| Date | Target | Acquirer | Value | Credited advisor | Source |
|---|---|---|---|---|---|
| Nov 17, 2026 | Cogitat | Indivi | Undisclosed | Not named in source | News |
| Nov 16, 2026 | Affineon Health | Credo Health | Undisclosed | Not named in source | Press release |
| Nov 11, 2026 | DrFirst | Inovalon | Undisclosed | Not named in source | News |
| Nov 10, 2026 | Counsel Health | Oura | $625M | Not named in source | News |
| Nov 10, 2026 | My Clinical Outcomes | Mayden | Undisclosed | Not named in source | News |
| Nov 9, 2026 | Medi24 | TeleClinic | Undisclosed | Not named in source | News |
| Nov 9, 2026 | Kouper Health | Ellipsis Health | Undisclosed | Not named in source | News |
| Nov 6, 2026 | Tuune | Fertifa | Undisclosed | Not named in source | News |
| Nov 5, 2026 | dacadoo | movement | Undisclosed | Not named in source | News |
| Nov 4, 2026 | Artiva HCx | VisiQuate | Undisclosed | Not named in source | Press release |
| Nov 2, 2026 | TailorMed | GrowthCurve | $250M | Not named in source | News |
Month by month
| Month | Deals announced | With a disclosed value | Naming an advisor |
|---|---|---|---|
| Nov 2026 | 11 | 2 | 0 |
| Oct 2026 | 14 | 3 | 0 |
| Sep 2026 | 21 | 2 | 4 |
| Aug 2026 | 18 | 3 | 2 |
| Jul 2026 | 12 | 2 | 1 |
| Jun 2026 | 15 | 1 | 4 |
| May 2026 | 12 | 3 | 1 |
| Apr 2026 | 15 | 0 | 1 |
| Mar 2026 | 13 | 3 | 1 |
| Feb 2026 | 5 | 1 | 1 |
| Jan 2026 | 6 | 1 | 1 |
Advisors named on Healthtech deals
Each count below is a number of credited deals: deals where the linked public source names the advisor. It measures public naming, not market share, and 16 of 142 deals on this page name any advisor at all.
| Advisor | Credited deals | Sell-side credited deals | Buy-side credited deals | Largest disclosed credited deal | Credited deals, with source |
|---|---|---|---|---|---|
| Bailey & Company (profile) | 2 | 2 | 0 | Undisclosed |
|
| Houlihan Lokey (profile) | 2 | 1 | 1 | Icario, $59.5M | |
| TripleTree (profile) | 2 | 1 | 1 | Undisclosed | |
| William Blair (profile) | 2 | 0 | 2 | Undisclosed | |
| ATB Cormark | 1 | 1 | 0 | Kneat, $474.5M |
|
| BofA Securities (profile) | 1 | 1 | 0 | Undisclosed |
|
| Cain Brothers, a division of KeyBanc Capital Markets | 1 | 1 | 0 | Icario, $59.5M |
|
| CIBC Capital Markets | 1 | 1 | 0 | Kneat, $474.5M |
|
| EP Securities | 1 | 1 | 0 | Undisclosed |
|
| FT Partners (profile) | 1 | 1 | 0 | Undisclosed |
|
| Healthcare Growth Partners | 1 | 1 | 0 | Undisclosed |
|
| J.P. Morgan (profile) | 1 | 1 | 0 | Undisclosed |
|
| Jefferies (profile) | 1 | 1 | 0 | Weave, $650M |
|
| Oppenheimer | 1 | 1 | 0 | Undisclosed |
|
| Evercore (profile) | 1 | 0 | 1 | Undisclosed |
|
| Greenberg Advisors | 1 | 0 | 1 | Undisclosed |
|
| KPMG (profile) | 1 | 0 | 1 | Undisclosed |
|
| Scotiabank | 1 | 0 | 1 | Kneat, $474.5M |
|
| Synergy Advisors (profile) | 1 | 0 | 1 | Undisclosed |
|
All Healthtech deals
Showing 2 of 2 deals · Reset filters · Filters need JavaScript; they apply to the rows shown in the table.
Deals 141 to 142 of 142, newest first. Page 3 of 3.
| Date | Target | Acquirer | Buyer type | Sector | Geo (target → acquirer) | Value | Credited advisor | Source |
|---|---|---|---|---|---|---|---|---|
| CareRevon-demand healthcare workforce staffing platform | IntelyCare | Strategic | Healthtech | US → US | Undisclosed | Not named in source | Press release | |
| Stellation Careprovider analytics and referral optimization | Skylight Health | Strategic | Healthtech | US → US | Undisclosed | Not named in source | Press release |
Deals 141 to 142 of 142, newest first. Page 3 of 3.
Methodology
Sources. Public announcements only: PR Newswire and GlobeNewswire M&A feeds, Business Wire, SEC EDGAR 8-K filings, Google News and TechCrunch acquisition feeds, and advisor announcement pages. No PitchBook, Crunchbase or CB Insights data is scraped or reproduced.
What counts. An announced acquisition (signed or closed) where the target is a software, SaaS, internet or technology-enabled business. Minority investments, funding rounds and rumours are excluded.
Verification. Every row links to a source that returned HTTP 200 on the day it was added and names both the target and the acquirer. Advisor credits appear only when the advisor's name is in that source text. Deal values appear only when a dollar figure is in the source; otherwise the value is recorded as undisclosed and is never estimated.
Updates. The pipeline runs daily. Rows are de-duplicated on target plus acquirer; a press release or 8-K is preferred over a news article when both exist. Rows marked medium confidence have a sector or value inferred from the source text; low-confidence rows are not published.
Corrections. If a row is wrong or you have a public source naming an advisor, contact us and we will fix it in the next build.
Frequently asked questions
How many Healthtech deals does this page track?
142 deals announced between Jan 7, 2026 and Nov 17, 2026, 13 of them in the last 30 days. 21 carry a disclosed value and 16 name an advisor in the source.
What does "credited deals" mean?
A deal is credited to an advisor only when the public source linked on that row names the advisor. Deals where no advisor is named are shown as not named, never filled in. The count measures public naming, so it is lower than the number of deals that actually had an advisor.
Why do most Healthtech deals show no advisor or no value?
Most private-company acquisitions publish neither. We record a value only when a dollar figure appears in the source and an advisor only when the source names one.
Can I reuse this data?
Yes. It is CC BY 4.0. Download the CSV or JSON, or the sector record, and link back.
ProCloser.ai. "Healthtech Software M&A Deals (2026), ProCloser Tech M&A Deal Index." https://procloser.ai/deals/healthtech/. Updated 2026-11-18.
Get matched with the right advisor for your deal.
The advisors credited in this index work deals like yours every quarter. Tell us about your company and we will match you with a vetted M&A advisory firm in your sector and size range, including success-fee-only options. Free to sellers.